ACADIA Pharmaceuticals Initiates Phase II Trial of Pimavanserin for Adjunctive Treatment in Patients Biotech Investing
Enanta Pharmaceuticals Announces AbbVie’s Investigational Regimen of Glecaprevir/Pibrentasvir Shows High SVR Rates Biotech Investing
Cannabis Science Begins Buildout Greenhouse Space for Its First Nevada Cannabinoid Drug Development Land Deal Biotech Investing
Clearside Biomedical Announces First Patient Enrolled in Phase 1/2 Clinical Trial of Zuprata™ Biotech Investing
Ocular Therapeutix™ Announces Successful Topline Results from Phase 3 Clinical Trial of DEXTENZA™ Biotech Investing
